Trial Profile
A Multicenter Phase 2 Study of Oral N-Acetyl Dinaline (CI-994) in the Treatment of Patients With Advanced Myeloma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jul 2015
Price :
$35
*
At a glance
- Drugs Tacedinaline (Primary)
- Indications Myeloma
- Focus Therapeutic Use
- 18 Sep 2005 New trial record.